STRO
USDSutro Biopharma Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.100
Kõrge
$1.110
Madal
$1.030
Maht
0.07M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
92.2M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.88M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Sutro Biopharma to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
Equity Insider News Commentary – Optimism in the field of oncology is on the rise, thanks to the National Institutes of Health's latest annual...
HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target
HC Wainwright & Co. analyst Andres Maldonado reiterates Sutro Biopharma with a Neutral and maintains $2 price target.
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),
Seotud aktsiad
HUSA
Houston American Energy Corporation
SGMA
SigmaTron International Inc.
ALLO
Allogene Therapeutics Inc.
NTRA
Natera Inc.
XOMAO
XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.